<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><?covid-19-tdm ?><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57149</article-id><article-id pub-id-type="doi">10.7554/eLife.57149</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Evidence for transmission of COVID-19 prior to symptom onset</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-180585"><name><surname>Tindale</surname><given-names>Lauren C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7751-1042</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-180600"><name><surname>Stockdale</surname><given-names>Jessica E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7984-1010</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180597"><name><surname>Coombe</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180598"><name><surname>Garlock</surname><given-names>Emma S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180599"><name><surname>Lau</surname><given-names>Wing Yin Venus</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180602"><name><surname>Saraswat</surname><given-names>Manu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180603"><name><surname>Zhang</surname><given-names>Louxin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0260-824X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180604"><name><surname>Chen</surname><given-names>Dongxuan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52500"><name><surname>Wallinga</surname><given-names>Jacco</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-142983"><name><surname>Colijn</surname><given-names>Caroline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6097-6708</contrib-id><email>ccolijn@sfu.ca</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution>University of British Columbia</institution><addr-line><named-content content-type="city">Vancouver</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution>Simon Fraser University</institution><addr-line><named-content content-type="city">Burnaby</named-content></addr-line><country>Canada</country></aff><aff id="aff3"><label>3</label><institution>National University of Singapore</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff4"><label>4</label><institution>Centre for Infectious Disease Control, National Institute for Public Health and the Environment</institution><addr-line><named-content content-type="city">Bilthoven</named-content></addr-line><country>Netherlands</country></aff><aff id="aff5"><label>5</label><institution>Leiden University Medical Center</institution><addr-line><named-content content-type="city">Leiden</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Franco</surname><given-names>Eduardo</given-names></name><role>Senior Editor</role><aff><institution>McGill University</institution><country>Canada</country></aff></contrib><contrib contrib-type="editor"><name><surname>Lipsitch</surname><given-names>Marc</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard TH Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>22</day><month>06</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57149</elocation-id><history><date date-type="received" iso-8601-date="2020-03-23"><day>23</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-21"><day>21</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Tindale et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Tindale et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57149-v2.pdf"/><abstract><p>We collated contact tracing data from COVID-19 clusters in Singapore and Tianjin, China and estimated the extent of pre-symptomatic transmission by estimating incubation periods and serial intervals. The mean incubation periods accounting for intermediate cases were 4.91 days (95%CI 4.35, 5.69) and 7.54 (95%CI 6.76, 8.56) days for Singapore and Tianjin, respectively. The mean serial interval was 4.17 (95%CI 2.44, 5.89) and 4.31 (95%CI 2.91, 5.72) days (Singapore, Tianjin). The serial intervals are shorter than incubation periods, suggesting that pre-symptomatic transmission may occur in a large proportion of transmission events (0.4–0.5 in Singapore and 0.6–0.8 in Tianjin, in our analysis with intermediate cases, and more without intermediates). Given the evidence for pre-symptomatic transmission, it is vital that even individuals who appear healthy abide by public health measures to control COVID-19.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>The first cases of COVID-19 were identified in Wuhan, a city in Central China, in December 2019. The virus quickly spread within the country and then across the globe. By the third week in January, the first cases were confirmed in Tianjin, a city in Northern China, and in Singapore, a city country in Southeast Asia. By late February, Tianjin had 135 cases and Singapore had 93 cases. In both cities, public health officials immediately began identifying and quarantining the contacts of infected people.</p><p>The information collected in Tianjin and Singapore about COVID-19 is very useful for scientists. It makes it possible to determine the disease’s incubation period, which is how long it takes to develop symptoms after virus exposure. It can also show how many days pass between an infected person developing symptoms and a person they infect developing symptoms. This period is called the serial interval. Scientists use this information to determine whether individuals infect others before showing symptoms themselves and how often this occurs.</p><p>Using data from Tianjin and Singapore, Tindale, Stockdale et al. now estimate the incubation period for COVID-19 is between five and eight days and the serial interval is about four days. About 40% to 80% of the novel coronavirus transmission occurs two to four days before an infected person has symptoms. This transmission from apparently healthy individuals means that staying home when symptomatic is not enough to control the spread of COVID-19. Instead, broad-scale social distancing measures are necessary.</p><p>Understanding how COVID-19 spreads can help public health officials determine how to best contain the virus and stop the outbreak. The new data suggest that public health measures aimed at preventing asymptomatic transmission are essential. This means that even people who appear healthy need to comply with preventive measures like mask use and social distancing.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>COVID19</kwd><kwd>Sars-CoV-2</kwd><kwd>coronavirus</kwd><kwd>transmission</kwd><kwd>incubation</kwd><kwd>serial interval</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000023</institution-id><institution>Government of Canada</institution></institution-wrap></funding-source><award-id>Canada 150 Research Chair program</award-id><principal-award-recipient><name><surname>Colijn</surname><given-names>Caroline</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Control of COVID-19 will require strong case finding and isolation of exposed individuals because transmission can occur days prior to symptom onset.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The novel coronavirus disease, COVID-19, was first identified in Wuhan, Hubei Province, China in December 2019 (<xref ref-type="bibr" rid="bib19">Li et al., 2020b</xref>; <xref ref-type="bibr" rid="bib10">Huang et al., 2020</xref>). The virus causing the disease was soon named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (<xref ref-type="bibr" rid="bib11">Hui et al., 2020</xref>) and quickly spread to other regions of China and then across the globe, causing a pandemic with over 5 million cases and 300,000 deaths at the time of writing (<xref ref-type="bibr" rid="bib14">Johns Hopkins University, 2020</xref>). In Tianjin, a metropolis located at the north of China, the first case was confirmed on January 21, 2020 (<xref ref-type="bibr" rid="bib29">Tianjin Health Commission, 2020</xref>). Two days later, the first case was confirmed in Singapore (<xref ref-type="bibr" rid="bib23">Ministry of Health Singapore, 2020</xref>), a city country in Southeast Asia. As of February 28, 2020, 93 and 135 cases had been confirmed in Singapore and Tianjin (<xref ref-type="bibr" rid="bib23">Ministry of Health Singapore, 2020</xref>; <xref ref-type="bibr" rid="bib29">Tianjin Health Commission, 2020</xref>). The first Singapore COVID-19 case was confirmed as an individual who had travelled to Singapore from Wuhan. Many of the initial cases were imported from Wuhan, with later cases being caused by local transmission. Singaporean officials worked to identify potential contacts of confirmed cases; close contacts were monitored and quarantined for 14 days from their last exposure to the patient, and other low-risk contacts were put under active surveillance and contacted daily to monitor their health status. These early outbreaks continue to provide the opportunity to estimate key parameters to understand COVID-19 transmission dynamics.</p><p>We screened publicly available data to identify datasets for two COVID-19 clusters that could be used to estimate transmission dynamics. In both Singapore and Tianjin, the COVID-19 outbreak occurred within a relatively closed system where immediate public health responses were implemented, contacts were identified and quarantined, and key infection dates were tracked and updated daily. With its experiences in control of the SARS outbreak, the Singaporean government had been adopting a case-by-case control policy from January 2, 2020. Only close contacts of a confirmed case were monitored and quarantined for 14 days. In Tianjin, a number of COVID-19 cases were traced to a department store, where numerous customers and sales associates were likely infected. Additional customers who had potential contact were asked to come forward through state news and social media, as well as asked if they had visited the department store at various checkpoints in the city. All individuals identified as having visited the store in late January were quarantined and sections of the Baodi District where the store is located were sealed and put under security patrol.</p><p>We estimate the serial interval and incubation period of COVID-19 from clusters of cases in Singapore and Tianjin. The serial interval is defined as the length of time between symptom onset in a primary case (infector) and symptom onset in a secondary case (infectee), whereas the incubation period is defined as the length of time between an infectee’s exposure to a virus and their symptom onset. Both are important parameters that are widely used in modeling in infectious disease, as they impact model dynamics and hence fits of models to data. While the pandemic has progressed far beyond these early outbreaks, it remains the case that mathematical modelling, using parameters derived from estimates like these, is widely used in forecasting and policy.</p><p>The serial interval and incubation period distributions, in particular, can be used to identify the extent of pre-symptomatic transmission (i.e. viral transmission from an individual that occurs prior to symptom onset). There is evidence that pre-symptomatic transmission accounts for a considerable portion of COVID-19 spread (<xref ref-type="bibr" rid="bib4">Arons et al., 2020</xref>; <xref ref-type="bibr" rid="bib6">Baggett et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Li et al., 2020a</xref>) and it is important to determine the degree to which this is occurring (<xref ref-type="bibr" rid="bib25">Peak et al., 2020</xref>). Early COVID-19 estimates borrowed parameters from SARS (<xref ref-type="bibr" rid="bib33">Wu et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Jiang et al., 2020</xref>; <xref ref-type="bibr" rid="bib1">Abbott et al., 2020</xref>), but more recent estimates have been made using information from early clusters of COVID-19 cases, primarily in Wuhan. Depending on the population used, estimates for incubation periods have ranged from 3.6 to 6.4 days and serial intervals have ranged from 4.0 to 7.5 days (<xref ref-type="bibr" rid="bib19">Li et al., 2020b</xref>; <xref ref-type="bibr" rid="bib16">Ki and Task Force for 2019-nCoV, 2020</xref>; <xref ref-type="bibr" rid="bib5">Backer et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Linton et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Nishiura et al., 2020</xref>); however, it is crucial that the estimates of incubation period and serial interval are based on the same outbreak, and are compared to those obtained from outbreaks in other populations. Distinct outbreak clusters are ideal for understanding how COVID-19 can spread through a population with no prior exposure to the virus. Here, we estimate the portion of transmission that is pre-symptomatic based on estimates of the incubation period and serial interval. We estimate both quantities under two frameworks: first, we use samples as directly as is feasible from the data, for example assuming that the health authorities’ epidemiological inferences regarding who exposed whom and who was exposed at which times are correct. Second, we use estimation methods that allow for unknown intermediate cases, such that the presumed exposure and infection events may not be complete. We also separate the analysis of incubation period according to earlier and later phases of the outbreaks, since measures were introduced during the time frame of the data.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Descriptive analyses</title><p><xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref> show the daily counts, putative origin of the exposure and individual time courses for the Singapore and Tianjin data. In the Singapore dataset, new hospitalization and discharge cases were documented daily from January 23 to February 26, 2020. 66.7% (62/93) of the confirmed cases recovered and were discharged from the hospital by the end of the study period (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). The disease progression timeline of the 93 documented cases in <xref ref-type="fig" rid="fig1">Figure 1(c)</xref> indicates that symptom onset occurred 1.71 ± 3.01 (mean ± SD) days after the end of possible viral exposure window and cases were confirmed 7.43 ± 5.28 days after symptom onset. The mean length of hospital stay was 13.3 ± 6.01 days before individuals recovered and were discharged.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Singapore COVID-19 cases.</title><p>(<bold>a</bold>) Daily hospitalized cases and cumulative hospitalized and discharged cases. (<bold>b</bold>) Daily incidence with probable source of infection. (<bold>C</bold>) Disease timeline, including dates at which each case is unexposed, exposed, symptomatic, hospitalized, and discharged. Not all cases go through each status as a result of missing dates for some cases.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig1-v2.tif"/></fig><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tianjin COVID-19 cases.</title><p>(<bold>a</bold>) Daily and cumulative confirmed cases, cumulative discharges and daily death cases. (<bold>b</bold>) Daily incidence with probable source of infection. (<bold>c</bold>) Disease progression timeline; not all cases go through each status as a result of missing dates for some cases.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig2-v2.tif"/></fig><p>In the Tianjin dataset, new confirmed cases were documented daily from January 21 to February 22, 2020. 48.1% (65/135) recovered and 2.2% (3/135) had died by the end of the study period (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>). The timeline of the 135 cases is shown in <xref ref-type="fig" rid="fig2">Figure 2(c)</xref>. Symptom onset occurred 4.98 ± 4.83 (mean ± SD) days after the end of the possible viral exposure window. Cases were confirmed 5.23 ± 4.15 days after symptom onset. The duration of hospital stay of the Tianjin cases is unknown as the discharge date of each case was not available. In both datasets, daily counts decline over time, which is likely a combination of delays to symptom onset and between symptom onset and reporting, combined with the effects of strong social distancing and contact tracing.</p></sec><sec id="s2-2"><title>Incubation period</title><p>In the Singapore dataset, we find that the median incubation period in our direct analysis (without accounting for intermediate cases) is 5.32 days with the gamma distribution; shape 3.05 (95%CI 2.0, 3.84); and scale 1.95 (1.23, 2.34). The mean incubation period is 5.99 (95%CI 4.97, 7.14) days. In Tianjin, we find a median 8.06 days; shape 4.74 (3.35, 5.72); scale 1.83 (1.29, 2.04). The mean is 8.68 (7.72, 9.7) days. These results are summarised in <xref ref-type="table" rid="table1">Table 1</xref>, and we also fitted Weibull and log normal distributions; see <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>. These are consistent with, or slightly longer than, previous estimates, see <xref ref-type="table" rid="app1table5">Appendix 1—table 5</xref> for comparison.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Mean incubation period, serial interval and pre-symptomatic transmission.</title><p>Incubation periods are based on the gamma estimates because these are the most convenient for taking the covariation of serial intervals and incubation periods into account (done throughout the table). 95% CIs are provided in brackets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Without intermediates</th><th>Incubation (days)</th><th>Serial interval (days)</th><th>Mean difference (days)</th><th>Portion pre-symptomatic(-)</th></tr></thead><tbody><tr><td>Singapore (all)</td><td>5.99 (4.97, 7.14)</td><td>4.0 (2.73, 5.57)</td><td>1.99</td><td>0.74</td></tr><tr><td>Singapore (early)</td><td>5.91 (4.50,7.64)</td><td/><td>1.91</td><td>0.742</td></tr><tr><td>Singapore (late)</td><td>6.06 (4.70, 7.67 )</td><td/><td>2.06</td><td>0.744</td></tr><tr><td>Tianjin (all)</td><td>8.68 (7.72, 9.7)</td><td>5.0 (3.82, 6.12)</td><td>3.68</td><td>0.81</td></tr><tr><td>Tianjin (early)</td><td>6.88 (5.97,7.87)</td><td/><td>1.88</td><td>0.72</td></tr><tr><td>Tianjin (late)</td><td>12.4 (11.1,13.7)</td><td/><td>7.4</td><td>0.96</td></tr><tr><th colspan="5">Account for intermediates</th></tr><tr><td>Singapore <inline-formula><mml:math id="inf1"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula></td><td>4.91</td><td>4.17 (2.44, 5.89)</td><td>0.77</td><td>0.53</td></tr><tr><td>Singapore <inline-formula><mml:math id="inf2"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:math></inline-formula></td><td>4.43</td><td/><td>0.26</td><td>0.46</td></tr><tr><td>Singapore <inline-formula><mml:math id="inf3"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.15</mml:mn></mml:mrow></mml:math></inline-formula></td><td>4.12</td><td/><td>−0.05</td><td>0.41</td></tr><tr><td>Singapore <inline-formula><mml:math id="inf4"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula></td><td>3.89</td><td/><td>−0.28</td><td>0.38</td></tr><tr><td>Tianjin <inline-formula><mml:math id="inf5"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula></td><td>7.54</td><td>4.31 (2.91, 5.72)</td><td>3.23</td><td>0.79</td></tr><tr><td>Tianjin <inline-formula><mml:math id="inf6"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:math></inline-formula></td><td>6.89</td><td/><td>2.58</td><td>0.74</td></tr><tr><td>Tianjin <inline-formula><mml:math id="inf7"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.15</mml:mn></mml:mrow></mml:math></inline-formula></td><td>6.30</td><td/><td>1.99</td><td>0.67</td></tr><tr><td>Tianjin <inline-formula><mml:math id="inf8"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula></td><td>5.91</td><td/><td>1.6</td><td>0.64</td></tr></tbody></table></table-wrap><p>In Singapore, these estimates are based on a combination of cases for whom last possible exposure is given by travel, and later cases (for whom the presumed infector was used). In Tianjin, social distancing measures were implemented during the outbreak. We find that the estimated incubation period is different, particularly in Tianjin, for cases with symptom onset on or prior to January 31st: see <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>. The estimated median incubation period for pre-Feb one cases in Tianjin is 6.48 days; the <inline-formula><mml:math id="inf9"><mml:mrow><mml:mi>q</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>0.025</mml:mn><mml:mo>,</mml:mo><mml:mn>0.975</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> quantiles are (2.5, 13.3) days. In contrast, post-Jan 31 the median is 12.13 days with <inline-formula><mml:math id="inf10"><mml:mrow><mml:mi>q</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>0.025</mml:mn><mml:mo>,</mml:mo><mml:mn>0.975</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> quantiles (7.3, 18.7) days. The means are 6.88 (5.97, 7.87) days for early cases and 12.4 (11.1, 13.7) days for later cases. Social distancing seems unlikely to change the natural course of infection, but these results might be explained if exposure occurred during group quarantine or otherwise later than the last time individuals thought they could have been exposed. Pre-symptomatic transmission would enable this, if an individual was thought to have been exposed before group quarantine, but in actuality was exposed during quarantine by a pre-symptomatic individual. The time interval in the data would then not be a sample of the incubation period, instead it would be a sample of one or more generation times plus an incubation period.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Fitted gamma COVID-19 incubation period distributions (without intermediates).</title><p>Cases are defined as ‘early’ if they have symptom onset on or prior to January 31, and are classified ‘late’ otherwise.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig3-v2.tif"/></fig><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>COVID-19 incubation period Kaplan-Meier curves for (<bold>a</bold>) Singapore and (<bold>b</bold>) Tianjin.</title><p>Top panels show unstratified data (all cases with symptom onset given). Bottom panels show ‘early’ and ‘late’ cases, where early cases are defined as those with symptom onset on or prior to January 31, and late otherwise.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig4-v2.tif"/></fig><p>In Singapore, we find the same effect, although much less pronounced. The estimated median incubation time is 5.26, with (0.025, 0.975) quantiles of (1.30, 13.8) days for early cases (also defined as cases with symptom onset on or prior to January 31st) and 5.35 (quantiles (1.22, 14.6)) days for late-arising cases. The means are 5.91 (4.50, 7.64) days for early cases and 6.06 (4.70, 7.67) days for later cases. Fits of gamma and log-normal distributions are similar; see <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>. Changes in perception of exposure times after control measures were introduced (i.e. people may assume that they must have been exposed prior to control measures), together with pre-symptomatic transmission, could result in missing intermediate transmission events and hence lengthened incubation period estimates. This in part motivates our analysis with intermediate cases.</p><p>Our estimates of the incubation period with intermediates are similar, under the assumption that intermediates are relatively rare. Results are shown in <xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="table" rid="table1">Table 1</xref>. We find that the median of the bootstrapped mean incubation periods for Singapore with a low (0.05 per day) rate of unknown intermediates is 4.91 days (4.35, 5.69 95% bootstrap CI), compared to a generation time of 3.71 (2.36, 4.91) days. The Tianjin bootstrapped mean incubation period is 7.54 (6.76, 8.56 95% CI) days and the generation time is only 2.82 (1.83, 3.52) days. The estimates are lower when the assumed probability of unknown intermediates is higher. Indeed, if intermediates were present between assumed exposure and onset, naturally the generation time would be shorter than if they were not. The mean generation times are consistently shorter than the mean incubation periods, indicating that infection can occur prior to symptom onset. The difference is particularly pronounced in Tianjin, where long intervals were observed.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Mean incubation period and generation time estimates from the incubation period intermediates analysis, under the assumption that the scale parameter for both distributions is equal, shown with dependence on the mean number of unknown intermediate cases per day of the empirical time elapsed between exposure and symptom onset.</title><p>The incubation period is longer than the generation time, so this analysis suggests that symptom onset occurs after infectiousness begins. Top: Singapore. Bottom: Tianjin. The means are the scale times the shape, which is fixed at 2.1 in Singapore and 2.2 in Tianjin. Varying this fixed value for the shape parameter was not found to significantly impact the results.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig5-v2.tif"/></fig><p>However, this approach makes a number of assumptions and is limited by the fact that if we do not know the true infectors then we are also unlikely to know the true exposure. The data we have is well suited to this method in the sense that there were particular events where exposure is thought to have occurred, and so we can account for intermediates in the manner we have done, but we do not have information for the alternative scenario in which the true exposures were prior to those given in the data. This could happen if, for example, individuals were exposed before attending an event or before known contact, and developed symptoms well after it. Exposure would thus be wrongly attributed to the event or contact. We have accommodated this with uncertainty in the exposure intervals, in particular not insisting that individuals who are likely to be the index case for a cluster (e.g. who developed symptoms on the same day as an event) <italic>must</italic> have been exposed then, but instead allowing the possibility that they were exposed earlier.</p></sec><sec id="s2-3"><title>Serial intervals</title><p><xref ref-type="fig" rid="fig6">Figure 6</xref> represents the empirical serial intervals between all potential transmission case-pairs as noted in the data and represented in <xref ref-type="fig" rid="fig7">Figure 7</xref>, split into groups based on date of first symptom onset for each case-pair. The empirical mean serial intervals shorten in the ’late’ group in both Singapore and Tianjin; however, the empirically derived 95% confidence intervals overlap (Singapore early 4.44 (-2.81, 11.7) vs. late 3.18 (-1.52, 7.88); Tianjin early 5.48 (-0.968, 11.9) vs. late 4.18 (-2.33, 10.7)). Negative lower bounds are due to the high standard deviation.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Serial intervals of possible case pairs in (<bold>a</bold>) Singapore and (<bold>b</bold>) Tianjin.</title><p>Pairs represent a presumed infector and their presumed infectee plotted by date of symptom onset. Cases are defined as 'early' if they have symptom onset on or prior to January 31st.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig6-v2.tif"/></fig><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Network diagram for (<bold>a</bold>) Singapore (<bold>b</bold>) Tianjin.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig7-v2.tif"/></fig><p>Shortening serial intervals are expected as increased quarantine measures are enacted during the course of an outbreak and can be an indication of improved control through successful contact tracing, as seen in SARS (<xref ref-type="bibr" rid="bib21">Lipsitch et al., 2003</xref>). Our results suggest that serial intervals shortened as the outbreak progressed in both clusters, but they could also be due to right truncation. Accounting for this, we found that the mean serial intervals were 4 and 5 days (Singapore, Tianjin); a Cox regression found no significant difference between the early and late groups’ serial intervals. This estimate is made directly from case pairs in the data without accounting for intermediate infectors and co-primary infection, as in the ICC analysis.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows our ICC estimates of the mean and standard deviation for the serial intervals, with comparison to other analyses and assumptions in <xref ref-type="table" rid="app1table5">Appendix 1—table 5</xref>. The ICC method finds the mean serial interval to be 4.17 (2.44, 5.89 95% bootstrap CI) days (0.882 bootstrap standard deviation) for Singapore and 4.31 (2.91, 5.72) days (0.716 bootstrap sd) for Tianjin, using the first four cases in each cluster. This is consistent with the results with right truncation.</p></sec><sec id="s2-4"><title>Pre-symptomatic transmission</title><p>We estimated incubation periods and serial intervals with and without accounting for intermediate unknown cases. To estimate the portion of transmission that occurs before symptom onset, we compare the ‘direct’ (no intermediate) estimates of each, and the ‘indirect’ (accounting for intermediates) estimates of each. We estimate consistently shorter serial intervals than incubation period, suggesting that there is pre-symptomatic transmission.</p><p>We took the covariation of incubation periods and serial intervals (and of generation times and incubation periods) into account by sampling the intervals jointly before estimating the fraction of the relevant differences that are negative. Even accounting for correlation, the estimated fraction of pre-symptomatic transmission for Singapore is 0.74 (regardless of early/late split) and for Tianjin is 0.72, 0.96, 0.81 (early, late, all), based on the direct estimates of the incubation periods and serial intervals (see also <xref ref-type="fig" rid="fig8">Figure 8</xref>). When we use the incubation period estimates that account for intermediates, the portions pre-symptomatic transmission are 0.53 in Singapore and 0.79 in Tianjin, when the assumed ‘rate of appearance’ of intermediates <inline-formula><mml:math id="inf11"><mml:mi>r</mml:mi></mml:math></inline-formula> is 0.05 (i.e. when we assume a relatively low rate of unknown intermediates). If this rate <inline-formula><mml:math id="inf12"><mml:mi>r</mml:mi></mml:math></inline-formula> is increased, the portion of pre-symptomatic transmission decreases, but even for <inline-formula><mml:math id="inf13"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula> we estimate the pre-symptomatic portion to be 0.38 in Singapore and 0.64 in Tianjin.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Pre-symptomatic infection as estimated by samples of (serial interval - incubation period), accounting for covariation.</title><p>Top: Singapore. Bottom: Tianjin. Left: without intermediates. Right: accounting for intermediates. Grey vertical line: 0. Samples below zero indicate pre-symptomatic transmission. In all cases there is substantial pre-symptomatic transmission.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-fig8-v2.tif"/></fig><p>These results were obtained under an estimated correlation between the incubation period and serial interval of 0.289 in Tianjin. If instead the correlation were 0.1, the portion of pre-symptomatic transmission in Tianjin under <inline-formula><mml:math id="inf14"><mml:mi>r</mml:mi></mml:math></inline-formula> = 0.05, 0.1, 0.15 and 0.2, respectively, is estimated as 0.783, 0.725, 0.663 and 0.62. With correlation 0.8, the equivalent portions are 0.849, 0.781, 0.704 and 0.660. We therefore find that the degree of positive correlation does not greatly impact our estimates of pre-symptomatic transmission. We retain high estimates of the fraction pre-symptomatic in Tianjin, due to the long apparent incubation periods. It seems likely that these are an artifact of either pre-symptomatic transmission during quarantine/lockdown, or of other assumptions made about exposures in the creation of the original dataset. We conclude that overall for this data and under reasonable assumptions, we see evidence of at least 65% of transmission occurring before symptom onset.</p><p>In our direct analysis, we estimate that infection occurred on average 1.99 and 3.68 days before symptom onset of the infector (Singapore, Tianjin). Because the incubation period is different for early- and late-occurring cases in our data, on average transmission for early-occurring cases is 1.91 and 2.06 days before symptom onset (Singapore, Tianjin) and 1.88, 7.4 days before (Singapore, Tianjin) for late-occurring cases. Taking a low rate (<inline-formula><mml:math id="inf15"><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>) of potential unknown intermediate cases into account, the mean difference reduces to 0.77 and 3.23 days (Singapore, Tianjin), though we still estimate a significant portion of pre-symptomatic transmission (0.53, 0.79), as above.</p><p>Overall, serial intervals are robustly shorter than incubation periods in our analyses (<xref ref-type="table" rid="table1">Table 1</xref>). These estimates are strengthened by the fact that we have estimated both incubation period and serial interval in the same populations and by the fact that we obtain the same result in two distinct datasets. In both sets of estimates, samples of the incubation period minus serial interval are negative with probability 0.38 or higher (Singapore) and 0.64 or higher (Tianjin), and these lower bounds require a high rate of unknown intermediates early in the outbreak. This indicates that a substantial portion of transmission may occur before symptom onset (see Appendix 1 and <xref ref-type="fig" rid="fig8">Figure 8</xref>), consistent with the clinical observations reported by <xref ref-type="bibr" rid="bib27">Rothe et al., 2020</xref> and (<xref ref-type="bibr" rid="bib7">Bai et al., 2020</xref>).</p><p>Shorter serial intervals yield lower reproduction number estimates. For example, if the epidemic grows at a rate of 0.15 (doubling time of 4.6 days [<xref ref-type="bibr" rid="bib15">Jung et al., 2020</xref>], scenario 1), an estimated reproduction number using the mean of the bootstrapped estimates is <inline-formula><mml:math id="inf16"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mpadded width="+3.3pt"><mml:mn>1.76</mml:mn></mml:mpadded><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1.30</mml:mn><mml:mo>,</mml:mo><mml:mn>2.17</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula> with a serial interval of 4.17 days (Singapore) and <inline-formula><mml:math id="inf17"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mpadded width="+3.3pt"><mml:mn>1.95</mml:mn></mml:mpadded><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1.72</mml:mn><mml:mo>,</mml:mo><mml:mn>2.47</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula> with a serial interval of 4.3 days (Tianjin). In contrast, if a longer serial interval (7.5 days [<xref ref-type="bibr" rid="bib15">Jung et al., 2020</xref>; <xref ref-type="bibr" rid="bib19">Li et al., 2020b</xref>]) is used, the estimate is <inline-formula><mml:math id="inf18"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mn>3.05</mml:mn></mml:mrow></mml:math></inline-formula>. This is based on the relationship between <inline-formula><mml:math id="inf19"><mml:mrow><mml:mi>R</mml:mi><mml:mo>⁢</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>, serial interval, and growth rate, and is a simple estimate that does not take into account a complex and variable natural history of infection (<xref ref-type="bibr" rid="bib32">Wallinga and Lipsitch, 2007</xref>). It serves primarily to illustrate how our estimated serial intervals impact <inline-formula><mml:math id="inf20"><mml:mi>R</mml:mi></mml:math></inline-formula> in simple models for COVID-19 dynamics.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we use transmission clusters in two locations where cases have reported links, exposure and symptom onset times to estimate both the incubation period and serial interval of COVID-19. We make these datasets available in a convenient spreadsheet form; they were available publicly but the Singapore dataset was presented in free text updates and the Tianjin cluster was described on multiple sites and in graphical form, in Chinese. We anticipate that the datasets themselves will remain useful for understanding COVID-19’s early spread in these well-documented outbreaks.</p><p>The incubation period and serial interval are key parameters for transmission modeling and for informing public health interventions; modeling remains one of the primary policy aids in use in planning local and global COVID-19 responses. Serial intervals, together with R0, control the shape and distribution of the epidemic curve (<xref ref-type="bibr" rid="bib2">Anderson et al., 2004</xref>). They influence the disease’s incidence and prevalence, how quickly an epidemic grows, and how quickly intervention methods need to be implemented by public health officials to control the disease (<xref ref-type="bibr" rid="bib2">Anderson et al., 2004</xref>; <xref ref-type="bibr" rid="bib9">Fraser et al., 2004</xref>). In particular, the portion of transmission events that occur before symptom onset is a central quantity for infection control (<xref ref-type="bibr" rid="bib9">Fraser et al., 2004</xref>), and will impact the efficacy of contact tracing and case finding efforts (<xref ref-type="bibr" rid="bib25">Peak et al., 2020</xref>).</p><p>Singapore and Tianjin officials both reacted quickly when COVID-19 cases appeared and started implementing contact tracing and containment measures; however, there was a dramatic difference in the severity of the measures taken. The first case was identified in Singapore on Jan 23, 2020 and in Tianjin on Jan 21. By Feb 9, Singapore had identified 989 close contacts and implemented a travel advisory to defer all travel to Hubei Province and all non-essential travel to Mainland China, asked travellers to monitor their health closely for 2 weeks upon return to Singapore, and asked the public to adopt precautions including avoiding close contact with people who are unwell, practicing good hygiene and hand washing, and wearing a mask if they had respiratory symptoms (<xref ref-type="bibr" rid="bib23">Ministry of Health Singapore, 2020</xref>). Comparatively, by February 9 in Tianjin, 11,700 contacts were under observations and the Baodi district of almost 1 million people was placed under lockdown with restrictions including: one person per household could leave every 2 days to purchase basic needs, public gatherings were banned, no one could leave their homes between 10PM and 6AM without an exemption, entrances to Tianjin were put under control, and all the buses linking nearby provinces and cities were halted (<ext-link ext-link-type="uri" xlink:href="http://www.chinadaily.com">www.chinadaily.com</ext-link>). While Singapore contained the virus spread relatively well until mid-March, they reached 500 confirmed cases on March 23, 1000 cases on April 1, 10,000 cases on April 22, and 25,000 cases on May 13 (<xref ref-type="bibr" rid="bib23">Ministry of Health Singapore, 2020</xref>); Tianjin province began to flatten their epidemic curve by mid-to-late-February and had plateaued at 192 confirmed cases as of May 19 (<ext-link ext-link-type="uri" xlink:href="https://github.com/CSSEGISandData/COVID-19">github.com/CSSEGISandData/COVID-19</ext-link>).</p><p>In Singapore and Tianjin we estimated relatively short serial intervals. Of particular note, early estimates of R0 for COVID-19 used the SARS serial interval of 8.4 days (<xref ref-type="bibr" rid="bib1">Abbott et al., 2020</xref>; <xref ref-type="bibr" rid="bib22">Majumder and Mandl, 2020</xref>; <xref ref-type="bibr" rid="bib33">Wu et al., 2020</xref>). Our serial interval findings from two populations mirror those of <xref ref-type="bibr" rid="bib34">Zhao et al., 2020</xref> and (<xref ref-type="bibr" rid="bib24">Nishiura et al., 2020</xref>), who estimated a serial interval of 4.4 and 4.0 days. <xref ref-type="bibr" rid="bib8">Du et al., 2020</xref> obtain a similar estimate for the serial interval (3.96 days with 95% CI: 3.53–4.39) but with standard deviation 4.75 days, based on 468 cases in 18 provinces. Furthermore, we estimate the serial interval to be shorter than the incubation period in both clusters, which suggests pre-symptomatic transmission. This indicates that spread of SARS-CoV-2 is likely to be difficult to stop by isolation of detected cases alone. However, shorter serial intervals also lead to lower estimates of R0, and our serial intervals support R0 values just below 2; if correct this means that half of the transmissions need to be prevented to contain outbreaks.</p><p>We stratified the incubation period analysis for Tianjin by time of symptom onset (pre- or post- Jan 31, 2020; motivated by quarantine/social distancing measures) and found that the apparent incubation period was longer for those with post-quarantine symptom onset. The reason for this is unclear, but one possible explanation is that there were (unknown, therefore unreported) exposures during the quarantine period. If people are quarantined in groups of (presumed) uninfected cases, pre-symptomatic transmission in quarantine would result in true exposure times that are more recent than reported last possible exposure times.</p><p>Although it may seem contradictory that for example Singapore’s efforts were able to keep the epidemic under control using mainly case-based controls if pre-symptomatic transmission is common, it remains the case that detailed contact tracing combined with case finding may be key to limiting both symptomatic and pre-symptomatic spread. In Singapore, symptom-free close contacts of known cases were quarantined preemptively for 14 days, and other less high-risk contacts were placed under phone surveillance (<xref ref-type="bibr" rid="bib17">Lee et al., 2020</xref>). In addition, if case finding is able to prevent a large portion of symptomatic transmission, it seems logical that the remaining observed transmission may be pre-symptomatic. The large extent of pre-symptomatic spread that is occurring, however, may be one reason that the spread of COVID-19 in Singapore was ultimately only delayed and not prevented.</p><p>There are several limitations to this work. First, the times of exposure and the presumed infectors are uncertain, and the incubation period is variable. We have not incorporated uncertainty in the dates of symptom onset. We have used the mixture model approach for serial intervals to avoid assuming that the presumed infector is always the true infector, but the mixture does not capture all possible transmission configurations. Our R0 estimates are simple, based on a doubling time of 4.6 days, and could be refined with more sophisticated modeling in combination with case count data. We have not adjusted for truncation (e.g. shorter serial intervals are likely to be observed first) or the growth curve of the epidemic. However, the serial interval estimates are consistent between the two datasets, are robust to the parameter choices, and are consistently shorter than the estimated incubation times.</p><p>We estimated both the incubation period and the serial interval in Singapore and Tianjin COVID-19 clusters. Our results suggest that there is substantial transmission prior to onset of symptoms, as the serial interval is shorter than incubation period by 2–4 days. We find differences in estimated incubation period between early and later cases; this may be due to pre-symptomatic transmission or differences in reporting and/or in perceived exposure as the outbreak progressed, in the context of social distancing measures. Evidence of transmission from apparently healthy individuals makes broad-scale social distancing measures particularly important in controlling the spread of the disease.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Data</title><p>All datasets and R code are available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/carolinecolijn/ClustersCOVID19">github.com/carolinecolijn/ClustersCOVID19</ext-link>; <xref ref-type="bibr" rid="bib30">Tindale et al., 2020</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/ClustersCOVID19">https://github.com/elifesciences-publications/ClustersCOVID19</ext-link>).</p><p>Singapore data was obtained from the <xref ref-type="bibr" rid="bib23">Ministry of Health Singapore, 2020</xref> online press releases. The Singapore dataset comprised 93 confirmed cases from the date of the initial case on January 23, 2020 until February 26, 2020. Tianjin data was obtained from the <xref ref-type="bibr" rid="bib29">Tianjin Health Commission, 2020</xref> online press releases. The Tianjin dataset comprises 135 cases confirmed from January 21 to February 22, 2020. The symptom onsets were available on the official website for all but a few patients who had not had symptoms before being diagnosed at a quarantine center. Both datasets contained mainly information on exposure times, contacts among cases, time of symptom onset (See Appendix 1 for column descriptions and data processing).</p></sec><sec id="s4-2"><title>Statistical analysis</title><p>All statistical analyses were performed using R (<xref ref-type="bibr" rid="bib26">R Development Core Team, 2013</xref>).</p><sec id="s4-2-1"><title>Incubation periods: not accounting for intermediate cases</title><p>The daily incidence of hospitalization and mortality was plotted with the cumulative number of cases confirmed and discharged. The daily incidence was also visualized by date of symptom onset. For the symptom onset plots, any cases that did not have information on date of onset of symptoms were removed. Cases were then grouped based on their assumed source of infection (see Appendix 1 for full details).</p><p>Incubation periods were estimated in two ways: directly from the exposure to symptom onset times, and using a model allowing for unknown intermediate cases to have been the true source of infection (see below). The direct estimates were based on the earliest and latest possible exposure times, and on the reported times of symptom onset. It is impossible to confirm the exact times of exposure and thus we used interval censoring, which uses the likelihood of a time falling in a defined window, (R package icenReg [<xref ref-type="bibr" rid="bib3">Anderson-Bergman, 2017</xref>]) to make parametric estimates of the incubation period distribution. For cases without a known earliest possible exposure time, we assume that the case must have been exposed within the 20 days prior to their symptom onset. For cases without a known latest possible exposure time, we assume that exposure had to have occurred before symptom onset. Some cases had a travel history or contact with a known location or presumed source of the virus and this defined their window for exposure. In the Singapore dataset, other individuals had estimated exposure times based on the symptom times for their presumed infector. For these, we define an exposure window using the symptoms of their presumed infector −7/+4 days. Having defined exposure windows, we proceed with interval censoring. In both datasets we stratified the data according to whether symptom onset occurred early or late, and estimated incubation periods separately. We define ‘early’ cases as those with symptom onset on or prior to January 31.</p></sec><sec id="s4-2-2"><title>Incubation periods: accounting for intermediate cases</title><p>Standard estimates of the incubation period from exposure and symptom data require knowledge of the true exposure event. In our data, exposures were frequently attributed to attendance at events or locations where there had been known COVID-19 cases. It is conceivable that some cases were not in fact exposed at the event, but subsequent to it, by an unknown (perhaps asymptomatic) case who also attended the event or was otherwise linked. We developed the following approach to account for possible unknown intermediates. Suppose the data suggest that case <inline-formula><mml:math id="inf21"><mml:mi>i</mml:mi></mml:math></inline-formula> was exposed at an event by individual <inline-formula><mml:math id="inf22"><mml:mi>A</mml:mi></mml:math></inline-formula>, but in fact, there is an unknown intermediate <inline-formula><mml:math id="inf23"><mml:mi>x</mml:mi></mml:math></inline-formula> who was infected at the event and who subsequently infected <inline-formula><mml:math id="inf24"><mml:mi>i</mml:mi></mml:math></inline-formula>. In this case, the time between <inline-formula><mml:math id="inf25"><mml:mi>i</mml:mi></mml:math></inline-formula>’s apparent exposure and <inline-formula><mml:math id="inf26"><mml:mi>i</mml:mi></mml:math></inline-formula>’s symptom onset is not a sample of the incubation period. Instead, it is one generation time (the time between <inline-formula><mml:math id="inf27"><mml:mi>A</mml:mi></mml:math></inline-formula> infecting <inline-formula><mml:math id="inf28"><mml:mi>x</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf29"><mml:mi>x</mml:mi></mml:math></inline-formula> infecting <inline-formula><mml:math id="inf30"><mml:mi>i</mml:mi></mml:math></inline-formula>) followed by one incubation period (from <inline-formula><mml:math id="inf31"><mml:mi>x</mml:mi></mml:math></inline-formula> infecting <inline-formula><mml:math id="inf32"><mml:mi>i</mml:mi></mml:math></inline-formula> to i’s symptoms). Similarly, if <inline-formula><mml:math id="inf33"><mml:mi>x</mml:mi></mml:math></inline-formula> infects a second unknown intermediate <inline-formula><mml:math id="inf34"><mml:mi>y</mml:mi></mml:math></inline-formula>, and <inline-formula><mml:math id="inf35"><mml:mi>y</mml:mi></mml:math></inline-formula> infects <inline-formula><mml:math id="inf36"><mml:mi>i</mml:mi></mml:math></inline-formula>, then the time elapsed is two generation intervals followed by an incubation period. Under the simplifying assumption that the generation time and the incubation period follow a gamma distribution with the same scale parameter, we can explicitly write the density for the elapsed time, given <inline-formula><mml:math id="inf37"><mml:mi>k</mml:mi></mml:math></inline-formula> intermediates. We model the assumption that longer times between (presumed) exposure and symptom onset have more room for undetected intermediate cases. To describe this with likelihoods, we model unknown intermediate cases occurring with a probability proportional to the length of the apparent incubation period, using a Poisson process (see Appendix 1). We estimate the mean incubation period and generation interval with this approach, also accounting for right truncation (which is not available in the interval censoring estimator in icenReg). If <inline-formula><mml:math id="inf38"><mml:mrow><mml:mi>f</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="inf39"><mml:mrow><mml:mi>g</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> are the densities for the incubation period and generation time respectively, then with <inline-formula><mml:math id="inf40"><mml:mi>k</mml:mi></mml:math></inline-formula> intermediates, the time elapsed has density <inline-formula><mml:math id="inf41"><mml:mrow><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mi>g</mml:mi><mml:mo>*</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>*</mml:mo><mml:mi>g</mml:mi><mml:mo>*</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msup><mml:mi>g</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>*</mml:mo><mml:mi>f</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, where * denotes convolution, i.e., <inline-formula><mml:math id="inf42"><mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>*</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo largeop="true" symmetric="true">∫</mml:mo><mml:mn>0</mml:mn><mml:mi>t</mml:mi></mml:msubsup><mml:mrow><mml:mi>g</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>s</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mi>f</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mi>s</mml:mi></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mrow><mml:mo>𝑑</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. The right trunctation time <inline-formula><mml:math id="inf43"><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> is the time between <inline-formula><mml:math id="inf44"><mml:mi>i</mml:mi></mml:math></inline-formula>’s exposure and the end of the observation period (because if the symptom onset does not happen after <inline-formula><mml:math id="inf45"><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> has elapsed it will not be observed, and this can bias estimates). Let the time from symptom onset to the beginning of the exposure window be <inline-formula><mml:math id="inf46"><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup></mml:math></inline-formula>, and to the end of the window <inline-formula><mml:math id="inf47"><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>i</mml:mi><mml:mo>⁢</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup></mml:math></inline-formula>. The incubation period is then somewhere in the interval <inline-formula><mml:math id="inf48"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>i</mml:mi><mml:mo>⁢</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. The likelihood of observing a time in this interval, conditional on <inline-formula><mml:math id="inf49"><mml:mi>k</mml:mi></mml:math></inline-formula> intermediates, is <inline-formula><mml:math id="inf50"><mml:mrow><mml:msubsup><mml:mi>L</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>i</mml:mi><mml:mo>⁢</mml:mo><mml:mi>n</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>. We use a Poisson process with rate <inline-formula><mml:math id="inf51"><mml:mi>r</mml:mi></mml:math></inline-formula> to model the probability that there are <inline-formula><mml:math id="inf52"><mml:mi>k</mml:mi></mml:math></inline-formula> intermediates. This means that the likelihood for the <inline-formula><mml:math id="inf53"><mml:mi>i</mml:mi></mml:math></inline-formula>’th observation is <inline-formula><mml:math id="inf54"><mml:mrow><mml:msup><mml:mi>L</mml:mi><mml:mi>i</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo largeop="true" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mn>3</mml:mn></mml:msubsup><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:msubsup><mml:mi>L</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. The complete likelihood is the product over all cases, <inline-formula><mml:math id="inf55"><mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mo largeop="true" symmetric="true">∏</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:msup><mml:mi>L</mml:mi><mml:mi>i</mml:mi></mml:msup></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></inline-formula> To compute this, note that if <inline-formula><mml:math id="inf56"><mml:mi>g</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf57"><mml:mi>f</mml:mi></mml:math></inline-formula> are both gamma densities with shapes <inline-formula><mml:math id="inf58"><mml:msub><mml:mi>a</mml:mi><mml:mi>g</mml:mi></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf59"><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula>, and if they have the same scale parameter <inline-formula><mml:math id="inf60"><mml:mi>b</mml:mi></mml:math></inline-formula>, then the convolution <inline-formula><mml:math id="inf61"><mml:mrow><mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mo>*</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mtext>Gamma</mml:mtext><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. We can extend this to <inline-formula><mml:math id="inf62"><mml:mi>k</mml:mi></mml:math></inline-formula> intermediates: the density is <inline-formula><mml:math id="inf63"><mml:mrow><mml:mrow><mml:msup><mml:mi>g</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>*</mml:mo><mml:mi>f</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mtext>Gamma</mml:mtext><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>⁢</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>g</mml:mi></mml:msub></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>,</mml:mo><mml:mi>b</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. We truncate the number of possible intermediates at <inline-formula><mml:math id="inf64"><mml:mi>n</mml:mi></mml:math></inline-formula>, so we condition the usual Poisson probability for <inline-formula><mml:math id="inf65"><mml:mi>k</mml:mi></mml:math></inline-formula> arrivals, <inline-formula><mml:math id="inf66"><mml:mrow><mml:msub><mml:mi>ρ</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:msup><mml:mi>r</mml:mi><mml:mi>k</mml:mi></mml:msup><mml:mo>⁢</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo lspace="0pt" rspace="3.5pt">!</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, accordingly. Let <inline-formula><mml:math id="inf67"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo largeop="true" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>r</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, and use<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mtd><mml:mtd><mml:mi>k</mml:mi><mml:mo>≤</mml:mo><mml:mi>n</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>We use maximum likelihood to estimate the shape parameters <inline-formula><mml:math id="inf68"><mml:msub><mml:mi>a</mml:mi><mml:mi>g</mml:mi></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf69"><mml:msub><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> of the generation and incubation periods under a range of intermediate ‘arrival rates’ <inline-formula><mml:math id="inf70"><mml:mi>r</mml:mi></mml:math></inline-formula> and we use bootstrapping to estimate the credible intervals. We refer to this analysis as the ‘incubation period with intermediates’ analysis.</p></sec><sec id="s4-2-3"><title>Serial intervals: not accounting for intermediates</title><p>We illustrate the empirical serial intervals implied by contact links reported in the data. We compute the mean and standard deviation of these in entirety, and separated into early- and late-occurring cases, calculating summary statistics of possible transmission pairs in ’early’ (i.e. first date of symptom onset on or before Jan 31, 2020) vs. ‘late‘ portions of both clusters. We estimate the mean serial intervals using these ‘directly reported’ contacts, accounting for right truncation (R package SurvTrunc) and using Cox proportional hazards to determine whether there is a significant early vs. late difference. We use the non-parametric survival curves to estimate the mean serial interval for both datasets.</p></sec><sec id="s4-2-4"><title>Serial intervals: accounting for intermediates</title><p>As with incubation periods, reported serial intervals may miss unknown intermediates, and co-infectors of two cases presumed to be a transmission pair. We used the expectation-maximization approach described in <xref ref-type="bibr" rid="bib31">Vink et al., 2014</xref>, which not only takes unknown intermediates into account but also explicitly models a fixed set of possible mis-allocation of infector-infectee pairs in contact data. Briefly, this approach assigns the case with earliest symptom onset in a cluster a ‘putative index’ (PI) status, and uses the time difference between symptom onset of subsequent cases in the cluster and the putative index as ‘index case to case’ (ICC) intervals for putative index cases in small, closely-linked sets of cases (‘small clusters’). The ICC intervals are the time differences between the symptom onset time <inline-formula><mml:math id="inf71"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mo>⁢</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> of the putative index (PI) case and the other members’ symptom onset (call these times <inline-formula><mml:math id="inf72"><mml:msub><mml:mi>t</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math></inline-formula>, where <inline-formula><mml:math id="inf73"><mml:mi>j</mml:mi></mml:math></inline-formula> is another case in the same small cluster as this PI). These intervals are not samples of the serial interval distribution, because it need not be the case that the PI infected the others. <xref ref-type="bibr" rid="bib31">Vink et al., 2014</xref> used a mixture model in which ICC intervals <inline-formula><mml:math id="inf74"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>p</mml:mi><mml:mo>⁢</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> can arise in four ways: (1) an outside case infects PI and <inline-formula><mml:math id="inf75"><mml:mi>j</mml:mi></mml:math></inline-formula>; (2) PI infects <inline-formula><mml:math id="inf76"><mml:mi>j</mml:mi></mml:math></inline-formula>; (3) PI infects an unknown who infects <inline-formula><mml:math id="inf77"><mml:mi>j</mml:mi></mml:math></inline-formula> and (4) PI infects unknown one who infects unknown two who infects <inline-formula><mml:math id="inf78"><mml:mi>j</mml:mi></mml:math></inline-formula>. Accordingly, if the serial interval <inline-formula><mml:math id="inf79"><mml:mrow><mml:mi>x</mml:mi><mml:mo>∼</mml:mo><mml:mrow><mml:mi class="ltx_font_mathcaligraphic">𝒩</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, the density for the ICC intervals is<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mrow><mml:mi>f</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>;</mml:mo><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:munder><mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:mrow><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>μ</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="inf80"><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> are weights of the <inline-formula><mml:math id="inf81"><mml:mi>i</mml:mi></mml:math></inline-formula>’th component density and <inline-formula><mml:math id="inf82"><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> are the component densities for the <inline-formula><mml:math id="inf83"><mml:mi>i</mml:mi></mml:math></inline-formula>’th transmission route. Expectation-maximization is used to determine <inline-formula><mml:math id="inf84"><mml:mi>μ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf85"><mml:mi>σ</mml:mi></mml:math></inline-formula> (See <xref ref-type="bibr" rid="bib31">Vink et al., 2014</xref> for more details).</p><p>For each dataset, we create a network, with individuals represented by nodes. The network’s edges are the reported direct contacts between individuals. Every such network (or graph) consists of one or more components – sets of nodes that are connected by edges. We use the components of the network to define transmission clusters. Since the four models in the mixture are likely insufficient to model the transmission in large clusters, we restrict the analysis to only the first four cases per cluster (or the first 3, 5, or 6 cases per cluster to determine impact of altering number of cases per cluster; see Appendix 1). We defined the first case within the cluster as the case with the earliest date of symptom onset within the cluster; however we also examined the impact of using the earliest end exposure time if the first symptomatic case was not the index case for the cluster (See Appendix 1). Given the serial interval, we calculate an approximate reproduction number using the empirical growth rate (<xref ref-type="bibr" rid="bib32">Wallinga and Lipsitch, 2007</xref>): <inline-formula><mml:math id="inf86"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>r</mml:mi><mml:mi>μ</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mi>r</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>, where <inline-formula><mml:math id="inf87"><mml:mi>r</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="inf88"><mml:mi>μ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf89"><mml:mi>σ</mml:mi></mml:math></inline-formula> are the exponential growth rate, the mean serial interval and the standard deviation of the serial interval, respectively). To obtain confidence intervals for <inline-formula><mml:math id="inf90"><mml:mi>R</mml:mi></mml:math></inline-formula> we resample <inline-formula><mml:math id="inf91"><mml:mi>μ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf92"><mml:mi>σ</mml:mi></mml:math></inline-formula> using bootstrapping.</p></sec><sec id="s4-2-5"><title>Pre-symptomatic transmission</title><p>We estimate the portion of transmission that occurs before symptoms as the fraction of samples where serial interval minus incubation period is negative. We introduce an approach to take covariation between the two variables into account, as follows. The mean difference between two random variables is the difference between the means. Therefore, the mean serial interval minus the mean incubation periods gives an estimate of the mean time before symptoms that transmission occurs according to our data. However, the distribution of the difference depends on the covariance between the incubation period and the serial interval. Unfortunately, it is challenging to obtain a good estimate of the covariance between these quantities. We estimated the covariance (and correlation) using case pairs; each pair is associated with two numbers: a serial interval estimate and an incubation period for the infectee. The covariance between these is a (somewhat crude) estimate of the covariance in the incubation period and serial intervals. We sampled incubation periods and serial intervals from our estimated distributions, ensuring that we respected the observed correlation, and used the serial interval - incubation period differences to estimate the portion of transmission that is pre-symptomatic. Further details of this approach are given in Appendix 1.</p><p>In estimating pre-symptomatic transmission, we compare ‘direct’ (not accounting for intermediates) incubation periods and serial intervals, and we compare the two <italic>with</italic> accounting for intermediates. We take the covariation into account throughout.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank the Ministry of Health Singapore and the Tianjin Health Commission for publishing information about cases through online press releases. We thank the participants of ’EpiCoronaHack’ at Simon Fraser University for their roles in curating these two datasets. We thank the public health teams and the patients whose data have been included in these analyses.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Validation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Visualization, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation</p></fn><fn fn-type="con" id="con9"><p>Data curation, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Software, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-57149-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Data are available on github at <ext-link ext-link-type="uri" xlink:href="https://github.com/carolinecolijn/ClustersCOVID19">https://github.com/carolinecolijn/ClustersCOVID19</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/ClustersCOVID19">https://github.com/elifesciences-publications/ClustersCOVID19</ext-link>). Code to produce all analyses is also available there. Source data files of the Singapore and Tianjin clusters have been provided.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname> <given-names>S</given-names></name><name><surname>Hellewell</surname> <given-names>J</given-names></name><name><surname>Munday</surname> <given-names>J</given-names></name><name><surname>Funk</surname> <given-names>S</given-names></name><collab>CMMID nCoV working group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The transmissibility of novel coronavirus in the early stages of the 2019-20 outbreak in Wuhan: exploring initial point-source exposure sizes and durations using scenario analysis</article-title><source>Wellcome Open Research</source><volume>5</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15718.1</pub-id><pub-id pub-id-type="pmid">32322691</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Fraser</surname> <given-names>C</given-names></name><name><surname>Ghani</surname> <given-names>AC</given-names></name><name><surname>Donnelly</surname> <given-names>CA</given-names></name><name><surname>Riley</surname> <given-names>S</given-names></name><name><surname>Ferguson</surname> <given-names>NM</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Lam</surname> <given-names>TH</given-names></name><name><surname>Hedley</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic</article-title><source>Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences</source><volume>359</volume><fpage>1091</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1098/rstb.2004.1490</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson-Bergman</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>icenReg: regression models for interval censored data in R</article-title><source>Journal of Statistical Software</source><volume>81</volume><elocation-id>i12</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v081.i12</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arons</surname> <given-names>MM</given-names></name><name><surname>Hatfield</surname> <given-names>KM</given-names></name><name><surname>Reddy</surname> <given-names>SC</given-names></name><name><surname>Kimball</surname> <given-names>A</given-names></name><name><surname>James</surname> <given-names>A</given-names></name><name><surname>Jacobs</surname> <given-names>JR</given-names></name><name><surname>Taylor</surname> <given-names>J</given-names></name><name><surname>Spicer</surname> <given-names>K</given-names></name><name><surname>Bardossy</surname> <given-names>AC</given-names></name><name><surname>Oakley</surname> <given-names>LP</given-names></name><name><surname>Tanwar</surname> <given-names>S</given-names></name><name><surname>Dyal</surname> <given-names>JW</given-names></name><name><surname>Harney</surname> <given-names>J</given-names></name><name><surname>Chisty</surname> <given-names>Z</given-names></name><name><surname>Bell</surname> <given-names>JM</given-names></name><name><surname>Methner</surname> <given-names>M</given-names></name><name><surname>Paul</surname> <given-names>P</given-names></name><name><surname>Carlson</surname> <given-names>CM</given-names></name><name><surname>McLaughlin</surname> <given-names>HP</given-names></name><name><surname>Thornburg</surname> <given-names>N</given-names></name><name><surname>Tong</surname> <given-names>S</given-names></name><name><surname>Tamin</surname> <given-names>A</given-names></name><name><surname>Tao</surname> <given-names>Y</given-names></name><name><surname>Uehara</surname> <given-names>A</given-names></name><name><surname>Harcourt</surname> <given-names>J</given-names></name><name><surname>Clark</surname> <given-names>S</given-names></name><name><surname>Brostrom-Smith</surname> <given-names>C</given-names></name><name><surname>Page</surname> <given-names>LC</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name><name><surname>Montgomery</surname> <given-names>P</given-names></name><name><surname>Stone</surname> <given-names>ND</given-names></name><name><surname>Clark</surname> <given-names>TA</given-names></name><name><surname>Honein</surname> <given-names>MA</given-names></name><name><surname>Duchin</surname> <given-names>JS</given-names></name><name><surname>Jernigan</surname> <given-names>JA</given-names></name><collab>Public Health–Seattle and King County and CDC COVID-19 Investigation Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>2081</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2008457</pub-id><pub-id pub-id-type="pmid">32329971</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Backer</surname> <given-names>JA</given-names></name><name><surname>Klinkenberg</surname> <given-names>D</given-names></name><name><surname>Wallinga</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020</article-title><source>Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin</source><volume>25</volume><elocation-id>2000062</elocation-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.5.2000062</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggett</surname> <given-names>TP</given-names></name><name><surname>Keyes</surname> <given-names>H</given-names></name><name><surname>Sporn</surname> <given-names>N</given-names></name><name><surname>Gaeta</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston</article-title><source>Jama</source><volume>323</volume><fpage>2191</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.6887</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname> <given-names>Y</given-names></name><name><surname>Yao</surname> <given-names>L</given-names></name><name><surname>Wei</surname> <given-names>T</given-names></name><name><surname>Tian</surname> <given-names>F</given-names></name><name><surname>Jin</surname> <given-names>D-Y</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Presumed asymptomatic carrier transmission of COVID-19</article-title><source>Jama</source><volume>323</volume><fpage>1406</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.2565</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Meyers</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The serial interval of COVID-19 from publicly reported confirmed cases</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.02.19.20025452</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname> <given-names>C</given-names></name><name><surname>Riley</surname> <given-names>S</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name><name><surname>Ferguson</surname> <given-names>NM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Factors that make an infectious disease outbreak controllable</article-title><source>PNAS</source><volume>101</volume><fpage>6146</fpage><lpage>6151</lpage><pub-id pub-id-type="doi">10.1073/pnas.0307506101</pub-id><pub-id pub-id-type="pmid">15071187</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>L</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Fan</surname> <given-names>G</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Gu</surname> <given-names>X</given-names></name><name><surname>Cheng</surname> <given-names>Z</given-names></name><name><surname>Yu</surname> <given-names>T</given-names></name><name><surname>Xia</surname> <given-names>J</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Yin</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Xiao</surname> <given-names>Y</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Guo</surname> <given-names>L</given-names></name><name><surname>Xie</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Jiang</surname> <given-names>R</given-names></name><name><surname>Gao</surname> <given-names>Z</given-names></name><name><surname>Jin</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Cao</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>The Lancet</source><volume>395</volume><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Hui</surname> <given-names>DS</given-names></name><name><surname>Azhar</surname> <given-names>DZ</given-names></name><name><surname>Madani</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health</article-title><conf-name>The Latest 2019 Novel Coronavirus Outbreak in Wuhan, China</conf-name><fpage>264</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.01.009</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Rayner</surname> <given-names>S</given-names></name><name><surname>Luo</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Does SARS-CoV-2 has a longer incubation period than SARS and MERS?</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>476</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1002/jmv.25708</pub-id><pub-id pub-id-type="pmid">32056235</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Jinyun News</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Jinyun news reference</article-title><ext-link ext-link-type="uri" xlink:href="https://m.weibo.cn/status/IrrHI1FHm?jumpfrom=weibocom">https://m.weibo.cn/status/IrrHI1FHm?jumpfrom=weibocom</ext-link><date-in-citation iso-8601-date="2020-02-28">February 28, 2020</date-in-citation></element-citation></ref><ref id="bib14"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Johns Hopkins University</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus resource center</article-title><ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/">https://coronavirus.jhu.edu/</ext-link><date-in-citation iso-8601-date="2020-05-22">May 22, 2020</date-in-citation></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Akhmetzhanov</surname> <given-names>AR</given-names></name><name><surname>Hayashi</surname> <given-names>K</given-names></name><name><surname>Linton</surname> <given-names>NM</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Yuan</surname> <given-names>B</given-names></name><name><surname>Kobayashi</surname> <given-names>T</given-names></name><name><surname>Kinoshita</surname> <given-names>R</given-names></name><name><surname>Nishiura</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Real-Time estimation of the risk of death from novel coronavirus (COVID-19) Infection: inference using exported cases</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>523</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9020523</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ki</surname> <given-names>M</given-names></name><collab>Task Force for 2019-nCoV</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea</article-title><source>Epidemiology and Health</source><volume>42</volume><elocation-id>e2020007</elocation-id><pub-id pub-id-type="doi">10.4178/epih.e2020007</pub-id><pub-id pub-id-type="pmid">32035431</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>VJ</given-names></name><name><surname>Chiew</surname> <given-names>CJ</given-names></name><name><surname>Khong</surname> <given-names>WX</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Interrupting transmission of COVID-19: lessons from containment efforts in Singapore</article-title><source>Journal of Travel Medicine</source><volume>27</volume><elocation-id>taaa039</elocation-id><pub-id pub-id-type="doi">10.1093/jtm/taaa039</pub-id><pub-id pub-id-type="pmid">32167146</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Fu</surname> <given-names>JB</given-names></name><name><surname>Li</surname> <given-names>KF</given-names></name><name><surname>Liu</surname> <given-names>JN</given-names></name><name><surname>Wang</surname> <given-names>HL</given-names></name><name><surname>Liu</surname> <given-names>LJ</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>YL</given-names></name><name><surname>Liu</surname> <given-names>SL</given-names></name><name><surname>Tang</surname> <given-names>A</given-names></name><name><surname>Tong</surname> <given-names>ZD</given-names></name><name><surname>Yan</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Transmission of COVID-19 in the terminal stages of the incubation period: a familial cluster</article-title><source>International Journal of Infectious Diseases</source><volume>96</volume><fpage>452</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.027</pub-id><pub-id pub-id-type="pmid">32194239</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Guan</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Tong</surname> <given-names>Y</given-names></name><name><surname>Ren</surname> <given-names>R</given-names></name><name><surname>Leung</surname> <given-names>KSM</given-names></name><name><surname>Lau</surname> <given-names>EHY</given-names></name><name><surname>Wong</surname> <given-names>JY</given-names></name><name><surname>Xing</surname> <given-names>X</given-names></name><name><surname>Xiang</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Tu</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Jin</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Zhou</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Shao</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Tao</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Deng</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Shi</surname> <given-names>G</given-names></name><name><surname>Lam</surname> <given-names>TTY</given-names></name><name><surname>Wu</surname> <given-names>JT</given-names></name><name><surname>Gao</surname> <given-names>GF</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Yang</surname> <given-names>B</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Feng</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Early transmission dynamics in Wuhan, China, of novel Coronavirus-Infected pneumonia</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1199</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linton</surname> <given-names>NM</given-names></name><name><surname>Kobayashi</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Hayashi</surname> <given-names>K</given-names></name><name><surname>Akhmetzhanov</surname> <given-names>AR</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Yuan</surname> <given-names>B</given-names></name><name><surname>Kinoshita</surname> <given-names>R</given-names></name><name><surname>Nishiura</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>538</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9020538</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Cohen</surname> <given-names>T</given-names></name><name><surname>Cooper</surname> <given-names>B</given-names></name><name><surname>Robins</surname> <given-names>JM</given-names></name><name><surname>Ma</surname> <given-names>S</given-names></name><name><surname>James</surname> <given-names>L</given-names></name><name><surname>Gopalakrishna</surname> <given-names>G</given-names></name><name><surname>Chew</surname> <given-names>SK</given-names></name><name><surname>Tan</surname> <given-names>CC</given-names></name><name><surname>Samore</surname> <given-names>MH</given-names></name><name><surname>Fisman</surname> <given-names>D</given-names></name><name><surname>Murray</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transmission dynamics and control of severe acute respiratory syndrome</article-title><source>Science</source><volume>300</volume><fpage>1966</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1126/science.1086616</pub-id><pub-id pub-id-type="pmid">12766207</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Majumder</surname> <given-names>M</given-names></name><name><surname>Mandl</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Early transmissibility assessment of a novel coronavirus in Wuhan, China, Available at SSRN</article-title><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2139/ssrn.3524675">http://dx.doi.org/10.2139/ssrn.3524675</ext-link><date-in-citation iso-8601-date="2020-02-28">February 28, 2020</date-in-citation></element-citation></ref><ref id="bib23"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Ministry of Health Singapore</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Updates on COVID-19 (Coronavirus disease 2019) Local situation</article-title><ext-link ext-link-type="uri" xlink:href="https://www.moh.gov.sg/covid-19">https://www.moh.gov.sg/covid-19</ext-link><date-in-citation iso-8601-date="2020-02-28">February 28, 2020</date-in-citation></element-citation></ref><ref id="bib24"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Nishiura</surname> <given-names>H</given-names></name><name><surname>Linton</surname> <given-names>NM</given-names></name><name><surname>Akhmetzhanov</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Serial interval of novel coronavirus (2019-nCoV) infections</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.02.03.20019497</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peak</surname> <given-names>CM</given-names></name><name><surname>Kahn</surname> <given-names>R</given-names></name><name><surname>Grad</surname> <given-names>YH</given-names></name><name><surname>Childs</surname> <given-names>LM</given-names></name><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Buckee</surname> <given-names>CO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study</article-title><source>The Lancet Infectious Diseases</source><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30361-3</pub-id><pub-id pub-id-type="pmid">32445710</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2013">2013</year><data-title>R: A Language and Environment for Statistical Computing</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname> <given-names>C</given-names></name><name><surname>Schunk</surname> <given-names>M</given-names></name><name><surname>Sothmann</surname> <given-names>P</given-names></name><name><surname>Bretzel</surname> <given-names>G</given-names></name><name><surname>Froeschl</surname> <given-names>G</given-names></name><name><surname>Wallrauch</surname> <given-names>C</given-names></name><name><surname>Zimmer</surname> <given-names>T</given-names></name><name><surname>Thiel</surname> <given-names>V</given-names></name><name><surname>Janke</surname> <given-names>C</given-names></name><name><surname>Guggemos</surname> <given-names>W</given-names></name><name><surname>Seilmaier</surname> <given-names>M</given-names></name><name><surname>Drosten</surname> <given-names>C</given-names></name><name><surname>Vollmar</surname> <given-names>P</given-names></name><name><surname>Zwirglmaier</surname> <given-names>K</given-names></name><name><surname>Zange</surname> <given-names>S</given-names></name><name><surname>Wölfel</surname> <given-names>R</given-names></name><name><surname>Hoelscher</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>970</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id><pub-id pub-id-type="pmid">32003551</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Tianjin Baodi People's Government</collab></person-group><year iso-8601-date="2020">2020</year><article-title>News, Hot Topics</article-title><ext-link ext-link-type="uri" xlink:href="http://www.tjbd.gov.cn/zjbd/gsgg/">http://www.tjbd.gov.cn/zjbd/gsgg/</ext-link><date-in-citation iso-8601-date="2020-02-28">February 28, 2020</date-in-citation></element-citation></ref><ref id="bib29"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Tianjin Health Commission</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Tianjin epidemic situation updates</article-title><ext-link ext-link-type="uri" xlink:href="http://wsjk.tj.gov.cn">http://wsjk.tj.gov.cn</ext-link><date-in-citation iso-8601-date="2020-02-28">February 28, 2020</date-in-citation></element-citation></ref><ref id="bib30"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tindale</surname> <given-names>LC</given-names></name><name><surname>Stockdale</surname> <given-names>JE</given-names></name><name><surname>Coombe</surname> <given-names>M</given-names></name><name><surname>Garlock</surname> <given-names>E</given-names></name><name><surname>Lau</surname> <given-names>WYV</given-names></name><name><surname>Saraswat</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>D</given-names></name><name><surname>Wallinga</surname> <given-names>J</given-names></name><name><surname>Colijn</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Analysis of novel Coronavirus Disease (COVID-19) Singapore and Tianjin outbreak clusters</data-title><source>GitHub</source><version designator="262">262</version><ext-link ext-link-type="uri" xlink:href="http://github.com/carolinecolijn/ClustersCOVID19">http://github.com/carolinecolijn/ClustersCOVID19</ext-link></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vink</surname> <given-names>MA</given-names></name><name><surname>Bootsma</surname> <given-names>MC</given-names></name><name><surname>Wallinga</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Serial intervals of respiratory infectious diseases: a systematic review and analysis</article-title><source>American Journal of Epidemiology</source><volume>180</volume><fpage>865</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1093/aje/kwu209</pub-id><pub-id pub-id-type="pmid">25294601</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallinga</surname> <given-names>J</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>How generation intervals shape the relationship between growth rates and reproductive numbers</article-title><source>Proceedings of the Royal Society B: Biological Sciences</source><volume>274</volume><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1098/rspb.2006.3754</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>JT</given-names></name><name><surname>Leung</surname> <given-names>K</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</article-title><source>The Lancet</source><volume>395</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30260-9</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Gao</surname> <given-names>D</given-names></name><name><surname>Zhuang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimating the serial interval of the novel coronavirus disease (COVID-19): A statistical analysis using the public data in hong kong from January 16 to February 15</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.02.21.20026559</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><sec id="s8" sec-type="appendix"><title>Details of the Singapore and Tianjin datasets</title><sec id="s8-1"><title>The Singapore dataset</title><p>In the Singapore dataset: ‘related cases’ are direct known contacts between cases; ‘cluster links’ are cases that are linked together through an identified cluster event; ‘presumed infected date’ and ‘presumed reason’ are the earliest known date and the reason that each case was known to likely be infected; ‘last poss exposure’ and ‘contact based exposure’ are sub-classifications of ‘presumed infected date’, representing either the last date that each case could have been infected – the date of arrival in Singapore for travellers from Wuhan – or the date that each case was likely infected during a local transmission event in Singapore, respectively; ‘cluster’ is the Ministry of Health Singapore’s classification of cases into transmission cluster events.</p><p>These data inform the ‘‘start_source’’ and ‘‘end_source’’ columns which encode the earliest and latest possible dates of case exposure. For example, we assume that those travelling from Wuhan were exposed before travel (due to evidence of lack of community transmission in Singapore at the time), and that those cases associated with a particular event or location (e.g., Grace Assembly gatherings, the visit to the Yong Thai store by a tour group from Wuhan) were not exposed prior to that event. For the latter, we set ‘‘end_source’’ to the date of the event +4 days, to allow for some uncertainty and the possibility of an intermediate infector. For cluster cases thought to originate from a particular index case but lacking information on dates of contact, ‘‘start_source’’ is set to the first symptom onset in the cluster -7 days. The ‘‘end_source’’ is set assuming that once a case in a cluster was identified, people were well aware of this and ceased mixing within the group; thus ‘‘end_source‘‘ is the minimum of the earliest quarantine, hospitalization or symptom onset in the cluster, and the symptom onset date of the case in question.</p><p>In the absence of other information, we set the ‘‘start_source’’ of a case to their symptom onset date - 20 days (to allow for a wide range of epidemiologically feasible incubation periods), and the ‘‘end_source’’ to their symptom onset (since all cases must be exposed before they show symptoms).</p><p>All cases in the Singapore dataset were categorized into an infection source group based on information provided in the ‘presumed reason' column without conflict. The group designations were not used in the statistical estimates.</p></sec></sec><sec id="s9" sec-type="appendix"><title>The Tianjin dataset</title><p>In the Tianjin cases summary spreadsheet, the main columns are: gender, age, symptom onset, symptom type, confirmation date, severity and death date <xref ref-type="bibr" rid="bib29">Tianjin Health Commission, 2020</xref>; detailed information from daily reports for the first 80 patients provided travel or exposure history and contact information, from which we obtained exposure windows (start source, end source). For backup and to complete missing information for later cases we also referred to <xref ref-type="bibr" rid="bib13">Jinyun News, 2020</xref>, Tianjin official local media, who used Baodi local government reports (<xref ref-type="bibr" rid="bib28">Tianjin Baodi People's Government, 2020</xref>). They reported detailed activity for those confirmed cases when their corresponding epidemiological history investigation was finished.</p><p>The ‘‘start_source’’ and ‘‘end_source’’ columns were defined similarly to the Singapore dataset where possible, with reasoning provided in the ‘‘Infection_source’’ column and further explanation in ‘‘recorrection for start and end source’’. In most cases, start and end times in the Tianjin dataset were defined by known windows of contact with other individuals with confirmed COVID-19 infections, the Baodi shopping mall or travel to areas with higher levels of infection such as Wuhan. Again, in the absence of other information, we set the ‘‘start_source’’ of a case to their symptom onset date -20 days and the ‘‘end_source’’ to their symptom onset.</p><p>Cases in the Tianjin dataset were categorized into an infection source group based on information provided in the the ‘‘Infection source‘‘ column. There were a small number of cases (n = 12) that could be classified into two possible infection source groups (e.g. from Wuhan and has a close relationship with another known case). These cases were assigned their infection source groups based on the following hierarchy of possible sources: (highest priority) Wuhan or Hubei origin &gt; Mall (for shoppers, workers, or individuals living near to the Baodi mall outbreak) &gt; Family relationship &gt; Work relationship &gt; Other known relationship &gt; Other travel &gt; Unknown (lowest priority).</p></sec><sec id="s10" sec-type="appendix"><title>Statistical methods</title><sec id="s10-1"><title>Incubation period</title><p>The ‘‘start_source’’ and ‘‘end_source’’ columns in each dataset are used to define the maximum and minimum possible incubation periods for each case. We additionally assume that incubation times have to be at least 1 day in length, and that the maximum incubation times are at least 3 days to take into account some uncertainty on symptom onset reporting.</p><p>We explored several distributions for the incubation period: gamma, Weibull and log normal. As shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>, once fit the resulting distributions all provide very similar results. <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> summarizes the parameter estimates for these three distributions. <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref> gives the parameters for the incubation period for early- and late-occurring cases in both datasets.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Incubation period estimates (without intermediates) using gamma, Weibull and log normal distributions.</title><p>95% confidence intervals for the shape and scale (log mean and sd for log normal) parameters are shown in brackets.</p></caption><table frame="hsides" rules="groups"><tbody><tr><th>Gamma</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td valign="top">Singapore Cluster</td><td>5.32</td><td>3.05 (2.0, 3.84)</td><td>1.95 (1.23, 2.34)</td></tr><tr><td valign="top">Tianjin Cluster</td><td>8.06</td><td>4.74 (3.35, 5.72)</td><td>1.83 (1.29, 2.04)</td></tr><tr><th>Weibull</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td valign="top">Singapore Cluster</td><td>5.66</td><td>1.83 (1.45, 2.30)</td><td>6.91 (5.77, 8.29)</td></tr><tr><td valign="top">Tianjin Cluster</td><td>8.59</td><td>2.41 (1.99, 2.90)</td><td>10.01 (8.94, 11.20)</td></tr><tr><th>Log normal</th><th>Median</th><th>Log mean</th><th>Standard deviation</th></tr><tr><td valign="top">Singapore Cluster</td><td>4.83</td><td>1.57 (1.38, 1.81) (mean 4.81)</td><td>0.60 (0.47, 0.76)</td></tr><tr><td valign="top">Tianjin Cluster</td><td>7.66</td><td>2.04 (1.92, 2.22) (mean 7.69)</td><td>0.47 (0.39, 0.56)</td></tr></tbody></table></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Incubation period estimates (without intermediates) using stratified data</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Tianjin</th><th/><th/><th/></tr></thead><tbody><tr><th>Gamma</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td>Early</td><td>6.48</td><td>6.01 (3.61, 7.26)</td><td>1.140 (0.66,1.276)</td></tr><tr><td>Late</td><td>12.1</td><td>17.78 (9.52, 21.47)</td><td>0.695 (0.379,0.778)</td></tr><tr><th>Weibull</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td>Early</td><td>6.73</td><td>2.88 (2.16, 3.48)</td><td>7.643 (6.735, 8.553)</td></tr><tr><td>Late</td><td>12.6</td><td>4.34 (3.10, 5.24)</td><td>13.661 (12.245, 15.289)</td></tr><tr><th>Log normal</th><th>Median</th><th>Log mean</th><th>Standard deviation</th></tr><tr><td>Early</td><td>6.30</td><td>1.84 (1.70,2.03)</td><td>0.426 (0.331,0.547)</td></tr><tr><td>Late</td><td>12.0</td><td>2.48 (2.38,2.67)</td><td>0.233 (0.172,0.315)</td></tr><tr><th colspan="4">Singapore</th></tr><tr><th>Gamma</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td>Early</td><td>5.26</td><td>3.22 (1.67, 4.05)</td><td>1.818 (0.847,2.18)</td></tr><tr><td>Late</td><td>5.35</td><td>2.96 (1.68,3.72)</td><td>2.034 (1.132,2.439)</td></tr><tr><th>Weibull</th><th>Median</th><th>Shape</th><th>Scale</th></tr><tr><td>Early</td><td>5.51</td><td>2.05 (1.34,2.58)</td><td>6.587 (5.077,7.897)</td></tr><tr><td>Late</td><td>5.67</td><td>1.75 (1.29,2.21)</td><td>6.989 (5.408,8.38)</td></tr><tr><th>Log normal</th><th>Median</th><th>Log mean</th><th>Standard deviation</th></tr><tr><td>Early</td><td>4.91</td><td>1.59 (1.33,1.82)</td><td>0.598 (0.421,0.848)</td></tr><tr><td>Late</td><td>4.72</td><td>1.55 (1.25,1.78)</td><td>0.606 (0.441,0.834)</td></tr></tbody></table></table-wrap></sec><sec id="s10-2"><title>Serial interval</title><p>We used bootstrapping to explore the range for the point estimates of <inline-formula><mml:math id="inf93"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf94"><mml:mi>σ</mml:mi></mml:math></inline-formula> from the mixture model. <xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref> shows the results. The mean of the bootstrapped mean estimates is 4.49 ± 0.716 for Tianjin and 3.83 ± 0.882 days in Singapore. Bootstrap values are consistent with a serial interval that is considerably shorter than the incubation periods in both datasets. <xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref> shows the sensitivity analysis; we varied the the number of cases per cluster to include in the ICC interval data and we explored sorting the cases in the clusters according to the time of last exposure (i.e., the putative index status assigned to the individual with the earliest end to their exposure window, instead of the first symptomatic individual).</p><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>Bootstrap values of the mean serial interval for (left) Singapore and (right) Tianjin, based on 100 replicates using the first four cases in each cluster.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57149-app1-fig1-v2.tif"/></fig><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>Serial interval estimates: accounting for intermediates.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>ordering</th><th>Number cases per cluster</th><th><inline-formula><mml:math id="inf95"><mml:mi>μ</mml:mi></mml:math></inline-formula> (Tianjin)</th><th><inline-formula><mml:math id="inf96"><mml:mi>σ</mml:mi></mml:math></inline-formula> (Tianjin)</th><th><inline-formula><mml:math id="inf97"><mml:mi>μ</mml:mi></mml:math></inline-formula> (Singapore)</th><th><inline-formula><mml:math id="inf98"><mml:mi>σ</mml:mi></mml:math></inline-formula> (Singapore)</th></tr></thead><tbody><tr><td>Onset</td><td>3</td><td>4.17</td><td>0.998</td><td>4.03</td><td>1.06</td></tr><tr><td>Onset</td><td>4</td><td>4.31</td><td>0.935</td><td>4.17</td><td>1.06</td></tr><tr><td>Onset</td><td>5</td><td>4.43</td><td>0.999</td><td>4.43</td><td>1.09</td></tr><tr><td>Onset</td><td>6</td><td>4.54</td><td>1.05</td><td>4.76</td><td>1.15</td></tr><tr><td>Last Exposure</td><td>4</td><td>5.09</td><td>1.27</td><td>4.26</td><td>1.17</td></tr><tr><td>Bootstrap</td><td>4</td><td>4.49 (sd 0.716)</td><td>0.995 (sd 0.307)</td><td>3.83 (sd 0.882)</td><td>1.24 (sd 0.538)</td></tr></tbody></table></table-wrap><p>The primary analysis removes all cases that are missing dates of symptom onset. To explore the potential impact of removing cases we repeated the serial interval estimates—when accounting for intermediates—by including these missing cases with imputed dates of symptom onset. There are 10 cases with missing date of symptom onset in both Tianjin and Singapore datasets. All cases missing date of symptom onset have a date of confirmation for infection with SARS-CoV-2; therefore, imputed dates were calculated by: (date of confirmation for case) - (average difference between date of symptom onset and date of confirmation, for all cases used in main analysis). This average difference between date of symptom onset and date of confirmation is 5.23 days in Tianjin and 7.43 days in Singapore. Imputing dates in this manner assumes that dates of symptom onset are missing completely at random. This assumption seems reasonable as the range of date of confirmation for the 10 imputed cases covers the majority of the range of date of confirmation for cases in the main analysis, in both datasets (Feb one to Feb 22, 2020 for imputed cases vs. Jan 21 to Feb 22, 2020 for main analysis cases in Tianjin and Jan 31 to Feb 21, 2020 vs. Jan 23 to Feb 26, 2020 in Singapore). <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref> contains the results of serial interval estimates including cases with imputed date of symptom onset and demonstrates that there is no substantial difference compared to serial interval estimates from the main analysis where missing cases are removed (<xref ref-type="table" rid="app1table3">Appendix 1—table 3</xref>).</p><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Serial interval estimates: accounting for intermediates and using imputed dates of symptom onset</title></caption><table frame="hsides" rules="groups"><thead><tr><th>ordering</th><th>Number cases per cluster</th><th><inline-formula><mml:math id="inf99"><mml:mi>μ</mml:mi></mml:math></inline-formula> (Tianjin)</th><th><inline-formula><mml:math id="inf100"><mml:mi>σ</mml:mi></mml:math></inline-formula> (Tianjin)</th><th><inline-formula><mml:math id="inf101"><mml:mi>μ</mml:mi></mml:math></inline-formula> (Singapore)</th><th><inline-formula><mml:math id="inf102"><mml:mi>σ</mml:mi></mml:math></inline-formula> (Singapore)</th></tr></thead><tbody><tr><td>Onset</td><td>3</td><td>4.35</td><td>0.907</td><td>4.18</td><td>1.05</td></tr><tr><td>Onset</td><td>4</td><td>4.40</td><td>0.864</td><td>4.27</td><td>1.04</td></tr><tr><td>Onset</td><td>5</td><td>4.48</td><td>0.909</td><td>4.41</td><td>0.981</td></tr><tr><td>Onset</td><td>6</td><td>4.55</td><td>0.948</td><td>4.71</td><td>1.08</td></tr><tr><td>Last Exposure</td><td>4</td><td>4.81</td><td>0.948</td><td>4.62</td><td>2.11</td></tr><tr><td>Bootstrap</td><td>4</td><td>4.53 (sd 0.585)</td><td>0.941 (sd 0.358)</td><td>4.31 (sd 1.03)</td><td>1.50 (sd 0.629)</td></tr></tbody></table></table-wrap></sec><sec id="s10-3"><title>Pre-symptomatic transmission: methods details</title><p>We estimated the portion pre-symptomatic transmission taking into account that the serial interval and incubation period are not independent, as described in the main text. In Singapore, we found that the covariance is 5.88, the Pearson correlation is 0.43 (<inline-formula><mml:math id="inf103"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>) and the Spearman (rho = 0.174) and Kendall (tau = 0.134) correlations were not significant (<inline-formula><mml:math id="inf104"><mml:mrow><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.2</mml:mn></mml:mrow></mml:math></inline-formula>); this is an intermediate signal of covariation. In Tianjin the covariance was 2.63, the correlation 0.29 and the statistical signal similar. We used both our ‘direct’ and ‘intermediate’ incubation period analysis to determine the portion pre-symptomatic transmission, accounting for the covariation.</p><p>To do this, we first sampled the incubation period parameters using the fits to data in the main text. These fits include a variance estimate between the shape and scale parameters, so we sample the shape and scale accordingly (using the gamma distribution). We created 100 incubation period (shape, scale) pairs (i.e., 100 samples). There are samplers in R for multivariate distributions whose margins are both gamma (rmvgamma in the lcmix package) and of course multivariate normal samplers, but we do not have a sampler for jointly distributed random variables with a normal distribution on one margin and a gamma on the other. Therefore, we use a gamma distribution for the serial interval, with the same mean and variance as the normal distribution estimated directly from the case-pair data. We obtain 100 serial interval gamma (shape, scale) pairs with the appropriate mean and variance. For each of these 100 distributions, sample <italic>jointly</italic> 500 incubation periods and serial intervals, with correlation of approximately 0.3. We therefore have 100 × 500 = 50,000 joint samples of incubation period and serial interval. The fraction of the (serial interval minus incubation period) samples is an estimate of the fraction of transmission that is pre-symptomatic, accounting for covariation.</p><p>We take the same approach for the estimates that account for intermediates; therefore, we sample from the gamma distribution for the incubation period as estimated with intermediates, from the ICC estimate of the serial intervals (i.e., we sample 100 incubation period shape, scale pairs, and 100 generation time shape, scale pairs, and for each we create 500 samples of the incubation period and generation time, accounting for covariance). This yields the estimates in <xref ref-type="table" rid="table1">Table 1</xref> and the density plots in <xref ref-type="fig" rid="fig8">Figure 8</xref>.</p></sec></sec><sec id="s11" sec-type="appendix"><title>Additional published estimates</title><p>Estimates of incubation period and serial interval from other studies are shown in <xref ref-type="table" rid="app1table5">Appendix 1—table 5</xref>. Of note, the majority of studies do not estimate both incubation period and serial interval in the same population.</p><table-wrap id="app1table5" position="float"><label>Appendix 1—table 5.</label><caption><title>Mean incubation period and mean serial interval estimates for COVID-19 generated by other studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Data</th><th>Number of Cases</th><th>Mean Incubation Period (days)</th><th>Mean Serial Interval (days)</th><th>Reference</th></tr></thead><tbody><tr><td>Wuhan first cases</td><td>425</td><td>5.2 (95CI 4.1-7.0)</td><td>7.5 (95CI 5.3-19)</td><td><xref ref-type="bibr" rid="bib19">Li et al., 2020b</xref></td></tr><tr><td>South Korea first cases</td><td>24</td><td>3.6</td><td>4.6</td><td><xref ref-type="bibr" rid="bib16">Ki and Task Force for 2019-nCoV, 2020</xref></td></tr><tr><td>Travellers from Wuhan</td><td>88</td><td>6.4 (95CI 5.6-7.7)</td><td>-</td><td><xref ref-type="bibr" rid="bib5">Backer et al., 2019</xref></td></tr><tr><td>Diagnosis outside Wuhan (excluding Wuhan residents)</td><td>52</td><td>5.0 (95CI 4.2-6.0)</td><td>-</td><td><xref ref-type="bibr" rid="bib20">Linton et al., 2020</xref></td></tr><tr><td>Diagnosis outside Wuhan (including Wuhan residents)</td><td>158</td><td>5.6 (95CI 5.0-6.3)</td><td>-</td><td><xref ref-type="bibr" rid="bib20">Linton et al., 2020</xref></td></tr><tr><td>Transmission chains in Hong Kong</td><td>21 chains</td><td>-</td><td>4.4 (95CI 2.9-6.7)</td><td><xref ref-type="bibr" rid="bib34">Zhao et al., 2020</xref></td></tr><tr><td>Infector-infectee pairs*</td><td>28 pairs</td><td>-</td><td>4.0 (95CI 3.1-4.9)</td><td><xref ref-type="bibr" rid="bib24">Nishiura et al., 2020</xref></td></tr></tbody></table><table-wrap-foot><fn><p>*Note: included 3 infector-infectee pairs from this Singapore cluster. Remainder from Vietnam (4), South Korea (7), Germany (4), Taiwan (1) and China (9).</p></fn></table-wrap-foot></table-wrap></sec></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57149.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Lipsitch</surname><given-names>Marc</given-names></name><role>Reviewing Editor</role><aff><institution>Harvard TH Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lipsitch</surname><given-names>Marc</given-names> </name><role>Reviewer</role><aff><institution>Harvard TH Chan School of Public Health</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Miller</surname><given-names>Joel</given-names> </name><role>Reviewer</role><aff><institution>La Trobe University</institution></aff></contrib><contrib contrib-type="reviewer"><name><surname>Pitzer</surname><given-names>Virginia E</given-names></name><role>Reviewer</role><aff><institution>Yale School of Public Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This is a valuable contribution to the effort to understand the timing of transmission of COVID-19 relative to symptoms. It provides evidence that pre-symptomatic individuals contribute to transmission and thus efforts must be directed beyond simply isolating those who have symptoms. This study provides data in support of widespread adoption of social distancing and other transmission prevention measures.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Evidence for spread of COVID-19 prior to symptom onset supports the need for social distancing&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Marc Lipsitch as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Eduardo Franco as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Joel Miller (Reviewer #2); Virginia E. Pitzer (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional explanation and possibly new analyses are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is 'in revision at <italic>eLife</italic>'. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>The manuscript by Tindale et al. presents estimates of the incubation period and serial interval for SARS-CoV-2 based on publicly available datasets from Singapore and Tianjin, China, where control measures were applied early and there was well documented contract tracing. Based on their findings that estimates of the mean incubation period are longer than estimates of the serial interval, they conclude that substantial pre-symptomatic transmission must be occurring.</p><p>Essential revisions:</p><p>1) The SI should shorten as control measures become more stringent (finding contacts faster), but this is not discussed, only the slightly odd lengthening of the incubation period. For example such shortening was prominent in Lipsitch et al., 2003 for SARS. Comment please.</p><p>2) Ferguson et al. (Imperial College COVID Report 4) have noted a previously unappreciated bias in retrospective contact tracing that can inflate the number of short serial intervals or incubation period. The relevance is uncertain to me for this study, but should be addressed.</p><p>3) The data do indeed seem to support presymptomatic transmission to a significant degree. Can the authors be any more specific about the bounds on this? For example if the serial intervals and incubation periods were uncorrelated, or positively correlated, or if one estimated for each case a probability that transmission was before symptoms, what would the result be in terms of the actual proportion of transmission presymptomatic?</p><p>4) Assuming the answer to 3 is &quot;a lot&quot; as I suspect, there is a paradox here – that Singapore kept the epidemic under control for months with mainly case-based interventions before it failed, a situation that could not happen (I think) if most transmission was presymptomatic. These two facts (the analysis and the control that lasted until early April) seem to contradict each other. Please discuss.</p><p>5) We would like a little more discussion on the lengthening of the incubation period – could this simply mean that before the restrictions the interaction that is identified as transmitting wasn't responsible, but in fact the transmission had happened days earlier, perhaps in an earlier interaction of the two individuals? It would be nice if the authors can comment on why we can or cannot rule this possibility out.</p><p>6) A key concern is that, unlike the method used to estimate the serial interval, the approach used to estimate the incubation period assumes that all cases (and potential infectors) have been identified and confirmed, and does not allow for transmission from asymptomatic cases. This seems particularly problematic for the Singapore dataset, in which all of the data seems to be on hospitalized cases; thus, less severe cases may have been missed (unless all cases were hospitalized as a form of isolation there). In Tianjin, it is unclear whether confirmed cases were hospitalized or not, but seems likely that asymptomatic or mild infections may have been missed. The large increase in the estimated incubation period for the &quot;early&quot; vs. &quot;late&quot; cases suggests to me that exposure to asymptomatic/undetected cases is likely biasing the results, as one would expect a greater prevalence and thus higher risk of exposure to asymptomatic cases later on. If there was an undetected case in between a confirmed case and the purported index case, presumably the estimated incubation period would be reduced by ~50% (at least).</p><p>7) The method for estimating the serial interval, on the other hand, does allow for multiple (undetected) generations of transmission between confirmed cases in the mixture model. Thus, these two approaches make different assumption about the potential presence/role of asymptomatic cases. Furthermore, there is no real methods development here. The authors apply two different established methods to their data, rather than presenting a unified framework for estimating the incubation period and serial interval (which would be novel and considerably strengthen the analysis).</p><p>8) Lastly, the estimates of R0 that they present in the Abstract and main text are not based on the actual data from Singapore and Tianjin. Instead, they use their estimates of the serial interval mean and standard deviation for each setting and a point estimate of the growth rate (with no uncertainty) from a different study based on data for all of mainland China. Thus, it is misleading to suggest that these are the R0 estimates specifically for Singapore and Tianjin.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57149.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The SI should shorten as control measures become more stringent (finding contacts faster), but this is not discussed, only the slightly odd lengthening of the incubation period, For example such shortening was prominent in Lipsitch et al., 2003 for SARS. Comment please.</p></disp-quote><p>We have added Cleveland-style figures and compared serial intervals between the early and late phases (Figure 6), as well as adding a discussion of the reviewer’s point to the text (“Serial Intervals” section of the Results). The raw serial intervals do seem to shorten by about a day in both locations in later vs. early subsets of the data. We have also added survival analysis exploring whether this result might be due to right truncation. This did not find a significant difference between the early and late stages, though this does not rule out that shortening occurred. We have cited the Science paper.</p><disp-quote content-type="editor-comment"><p>2) Ferguson et al. (Imperial College COVID Report 4) have noted a previously unappreciated bias in retrospective contact tracing that can inflate the number of short serial intervals or incubation period. The relevance is uncertain to me for this study, but should be addressed.</p></disp-quote><p>Report 4 is an analysis of the case fatality rate and so we are not certain what the previously unappreciated bias is. We agree that contact tracing can be biased in a number of ways, including towards close contacts who individuals are likely to be able to name, recollected exposures more likely to be recent ones, and right truncation – the fact that individuals with earlier symptom onset are observed sooner (though this will affect both serial intervals and incubation periods). We acknowledge in Appendix 1 that we have not accounted for these effects, and have commented on this in the Discussion. We also adjusted for right truncation in our new analysis accounting for intermediate cases in the incubation period estimates (see below).</p><disp-quote content-type="editor-comment"><p>3) The data do indeed seem to support presymptomatic transmission to a significant degree. Can the authors be any more specific about the bounds on this? For example if the serial intervals and incubation periods were uncorrelated, or positively correlated, or if one estimated for each case a probability that transmission was before symptoms, what would the result be in terms of the actual proportion of transmission presymptomatic?</p></disp-quote><p>This is a challenging and interesting question. In fact one of the reasons that we didn’t highlight our pre-symptomatic fractions more in the first version was that we were aware that subtracting independent samples from two distributions does not give a good estimate of the distribution of differences (only the difference in mean, by linearity). We have developed this aspect of the work considerably, and we now account for correlations. To do this, we estimated the covariance (and correlation) of the serial interval and incubation period distribution using the “direct” samples, i.e. as taken as directly as possible from the data. We then resampled jointly from our estimated distributions, accounting for this level of covariation. Surprisingly, this did not make as much difference to the portion of samples of (serial interval minus incubation period) that are negative as we would have guessed. These remain high, and are higher in Tianjin than in Singapore. The analysis is at the end of the Materials and methods and Results section and the sampling method (based on multivariate distributions with marginal gamma densities) is given in Appendix 1, subsection “Pre-symptomatic transmission: methods details”.</p><disp-quote content-type="editor-comment"><p>4) Assuming the answer to 3 is &quot;a lot&quot; as I suspect, there is a paradox here – that Singapore kept the epidemic under control for months with mainly case-based interventions before it failed, a situation that could not happen (I think) if most transmission was presymptomatic. These two facts (the analysis and the control that lasted until early April) seem to contradict each other. Please discuss.</p></disp-quote><p>The answer to 3 does appear to be “quite a lot” – about half or even more in the new Table 1. We agree that this is a good point and have added details to the Discussion. Essentially, we do not think that pre-symptomatic transmission necessarily renders case-based interventions ineffective, so long as contact tracing is thoroughly implemented and is complemented with strong case finding. In Singapore, symptom-free close contacts were preemptively quarantined – we suspect this minimized community presymptomatic transmission once a cluster is identified. We cite Lee, Chiew and Khong, 2020, for containment efforts.</p><p>Also, if effective case finding limits the amount of symptomatic transmission that occurs, it makes sense that the proportion of presymptomatic spread we find would be higher, since this represents the remaining transmission that was not prevented.</p><disp-quote content-type="editor-comment"><p>5) We would like a little more discussion on the lengthening of the incubation period – could this simply mean that before the restrictions the interaction that is identified as transmitting wasn't responsible, but in fact the transmission had happened days earlier, perhaps in an earlier interaction of the two individuals? It would be nice if the authors can comment on why we can or cannot rule this possibility out.</p></disp-quote><p>Yes, we suspect that this must be to do with the interactions assumed to be responsible for exposure being mis-allocated for Tianjin. We have updated the data and some of the assumptions around exposure and we now find that the early-late difference is only significant in Tianjin. In fact this is consistent with pre- or asymptomatic transmission; if individuals were exposed to someone with symptoms, and then later exposed to an individual without symptoms (for example in a group quarantine setting), the exposure would be likely attributed to pre-quarantine contact and the time interval in the data would not be a sample of the incubation period. Instead, it would be a sample of one or more generation times plus an incubation period – see below. We have added discussion of this in the incubation period Results section.</p><disp-quote content-type="editor-comment"><p>6) A key concern is that, unlike the method used to estimate the serial interval, the approach used to estimate the incubation period assumes that all cases (and potential infectors) have been identified and confirmed, and does not allow for transmission from asymptomatic cases. This seems particularly problematic for the Singapore dataset, in which all of the data seems to be on hospitalized cases; thus, less severe cases may have been missed (unless all cases were hospitalized as a form of isolation there). In Tianjin, it is unclear whether confirmed cases were hospitalized or not, but seems likely that asymptomatic or mild infections may have been missed. The large increase in the estimated incubation period for the &quot;early&quot; vs. &quot;late&quot; cases suggests to me that exposure to asymptomatic/undetected cases is likely biasing the results, as one would expect a greater prevalence and thus higher risk of exposure to asymptomatic cases later on. If there was an undetected case in between a confirmed case and the purported index case, presumably the estimated incubation period would be reduced by ~50% (at least).</p></disp-quote><p>This is a good point. Please see the response to the related point :</p><disp-quote content-type="editor-comment"><p>7) The method for estimating the serial interval, on the other hand, does allow for multiple (undetected) generations of transmission between confirmed cases in the mixture model. Thus, these two approaches make different assumption about the potential presence/role of asymptomatic cases. Furthermore, there is no real methods development here. The authors apply two different established methods to their data, rather than presenting a unified framework for estimating the incubation period and serial interval (which would be novel and considerably strengthen the analysis).</p></disp-quote><p>We have introduced another analysis with what we believe is a novel method. As noted above, if there were unknown intermediates, then the sampled “incubation period” would instead be a sample of a sum of generation intervals: A infects B, B infects C, … followed by an incubation period: C’s time from exposure to symptom onset. Under the assumption that the incubation period and generation time can be modelled as a gamma distribution, it is possible to write down the likelihood for the time from A’s exposure (at an event, say, or mass gathering) and C’s symptom onset, because the density is a convolution of gamma densities. We have developed a new analysis along these lines, and we do indeed find shorter incubation periods than without intermediates. We also find that the incubation period is longer than the generation time, giving an alternative point of support for the conclusion about pre-symptomatic transmission. To our knowledge this, combined with the covariance analysis described above, is a novel methodological contribution.</p><disp-quote content-type="editor-comment"><p>8) Lastly, the estimates of R0 that they present in the Abstract and main text are not based on the actual data from Singapore and Tianjin. Instead, they use their estimates of the serial interval mean and standard deviation for each setting and a point estimate of the growth rate (with no uncertainty) from a different study based on data for all of mainland China. Thus, it is misleading to suggest that these are the R0 estimates specifically for Singapore and Tianjin.</p></disp-quote><p>We agree and have modified the wording. R0 estimation (in any sense, never mind for specific populations) was never a primary focus of the work and this section is only there to note that models using SARS-like serial intervals (7.5 days) would conclude that R0 was higher than models using our serial interval estimates of 4+ days. We have amended this.</p></body></sub-article></article>